Printer Friendly

The effect of media supplementation with angiotensin on developmental competence of ovine embryos derived from vitrified-warmed oocytes.

Abstract

Background: This study was aimed to assess the effects of angiotensin II (Ang II) supplementation to the In Vitro Maturation (IVM) and In Vitro Culture (IVC) media of vitrified-warmed ouine oocytes on their developmental competence and expression of [Na.sup.+]/[K.sup.+]/ATPase in resulting embryos.

Methods: The slaughterhouse-derived immature oocytes (n=1069) were randomly distributed into four experimental groups: groups I and II) IVM/IVF and IVC of fresh and vitrified oocytes without angiotensin supplementation (Control-Fresh and Control-Vit groups, respectively); group III) IVM of vitrified oocytes in the presence of Ang II followed by IVF/IVC (Vit-IVM group); and group IV) IVM/IVF of vitrified oocytes followed by IVC wherein the embryos were exposed to Ang II on day 4 of IVC (Vit-D4 group). The embryos were immunostained with primary antibodies against [Na.sup.+]/[K.sup.+]/ATPase [[alpha].sub.1] and [[beta].sub.1], subunits.

Results: In Vit-IVM and Vit-D4 groups, the rates of expanded and total blastocysts on day 7 as well as the proportion of blastocysts on day 8 were increased. The expression of [Na.sup.+]/[K.sup.+]/ATPase [[beta].sub.1], and [[beta].sub.1], subunits were positively influenced by the addition of Ang II on day 4 (Vit-D4 group).

Conclusion: The addition of Ang II to the IVM and IVC media could improve blastocysts formation in vitrified sheep oocytes. This improvement might be related to the greater expression of [Na.sup.+][K.sup.+]ATPase [[alpha].sub.1], and [[beta].sub.1], subunits when Ang II was added during IVC.

Keywords: Angiotensin II, [Na.sup.+]/[K.sup.+]ATPase, Oocytes, Ovine, Vitrification

Introduction

Oocyte cryopreservation is becoming an integral part of Assisted Reproductive Technologies (ARTs) as an approach for female fertility preservation and conservation of endangered animal species as well as preserving the female genome of valuable laboratory models (1). For ovine oocytes, further attention to the effects of vitrification on gene and protein expression could be fruitful for overcoming the developmental blocks seen in this and other species (2). There are evidences indicating that alteration of culture conditions and media during oocyte maturation, fertilization, and embryo development have improved the production of embryos derived from vitrified oocytes (3,5). However, the rates of embryo development and pregnancy following cryopreservation of in vitro matured oocytes are lower than those obtained from in vivo matured oocytes (6-8). The presence of renin-angiotensin components has been shown in the oviduct, placenta, and foetal membranes of various species (9,10). The presence of high concentration of Ang II receptors, especially AGTR2, has also been reported in mouse, rat, and human fetuses (11). The high concentrations of Ang II in mammalian ovaries may indicate its role in ovarian function (12). In this context, the concentrations of Ang II has been increased in human and bovine follicular fluid at the time of ovulation and following exposure to Luteinizing Hormone (LH) or human Chorionic Gonadotropin (hCG) (6). Addition of saralasin (Ang II antagonist), however, could inhibit hCG-induced oocyte maturation (3). There is also evidence indicating direct effect of Ang II on ovarian steroidogenesis, follicular atresia, oocyte maturation, and ovulation (13).

Some genes were indicated as being controlled by Ang II such as [Na.sup.+][K.sup.+]/ATPase (14), Nicotinamide Adenine Dinucleotide Phosphate (NADPH), Mitogen-Activated Protein Kinases (MAPKs) and Cycloxygenase-2 (COX-2) (15). Studies have been indicated that sheep oocyte cryopreservation reduces mRNA levels of several critical genes including [Na.sup.+]/[K.sup.+]/ATPase (3, 16).

There are some evidences indicating positive role of [Na.sup.+]/[K.sup.+]/ATPase during blastocyst formation in mouse including: (a) polarized dissemination of [Na.sup.+]/[K.sup.+]/ ATPase just before beginning of cavitation, (b) increased [Na.sup.+]/[K.sup.+]/ATPase subunits expression during morula to blastocyst conversion, (c) inhibitory effect of ouabain (as a [Na.sup.+]/[K.sup.+]/ATPase inhibitor) on blastocyst development in some mammalians, and (d) positive role of [Na.sup.+]/[K.sup.+]/ATPase in function of trophectoderm tight junctions (17).

Considering the increase in [Na.sup.+]/[K.sup.+]/ATPase expression during morula to blastocyst transition (17) and the reduction of [Na.sup.+]/[K.sup.+]/ATPase mRNA abundance caused by vitrification (16), this study was aimed to evaluate the effect of addition of Ang II to the In Vitro Maturation (IVM) and In Vitro Culture (IVC) media of vitrified-warmed ovine oocyte on its subsequent developmental competence as well as the expression of [Na.sup.+]/[K.sup.+]/ ATPase in resulting embryo.

Materials and Methods

All experimental methods were confirmed by Avicenna Research Institute Bioethics Committee. Except where otherwise indicated, all chemicals were obtained from Sigma-Aldrich Co. (St. Louis, MO, USA).

Experimental groups

The immature oocytes, after aspiration, were randomly allocated into the following groups: groups I and II) IVM/IVF and IVC of vitrified and fresh oocytes without angiotensin supplementation (Control-Vit and Control-Fresh groups, respectively); group III) IVM of vitrified oocytes in the presence of [10.sup.10] M Ang II followed by in vitro fertilization (IVF)/IVC (Vit-IVM group); group IV) IVM/IVF of vitrified oocytes followed by IVC wherein the embryos were exposed to [10.sup.10] M Ang II on day 4 of IVC (Vit-D4 group).

The zygotes were then cultured in SOF medium at 39[degrees]C under condition of 7% [O.sub.2], 5% C[O.sub.2] and 88% [N.sub.2] in humidified air for 8 days. The rates of cleavage and blastocyst/hatching were recorded on days 3 and 6 to 8, respectively (day 0 was defined as the day of fertilization). Each treatment was consisted of at least four replicates. To evaluate the effects of Ang II on [Na.sup.+]/[K.sup.+]/ ATPase subunits expression, the morula and blastocyst embryos on day 8 were immunostained with different specific primary and a common Fluorescein Isothiocyanate (FITC)-conjugated secondary antibodies. The mean fluorescence intensity of the subunits was measured with ImageJ 1.37v software (National Institutes of Health, Bethesda, MD, USA).

In vitro maturation

Slaughterhouse-derived sheep ovaries were collected in 0.9% saline solution fortified with antibiotics at 35[degrees]C and carried within 2 hr to the laboratory. All follicles measuring 2 to 6 mm were aspirated with a 20-gauge needle attached to a 5 ml syringe. Oocytes with at least three intact layers of cumulus cells and homogenous cytoplasm were selected for in vitro maturation. Oocytes were matured in medium consisted of Tissue Culture Media 199 (TCM199) supplemented with 10% (v/v) Fetal Bovine Serum (FBS), 0.2 mM Na-pyrovate, 0.05 U/ml follicle stimulating hormone (FSH), 100 IU/ ml penicillin, and 0.1 mM streptomycin. The selected Cumulus Oocyte Complexes (COCs) were placed in maturation medium (10 oocytes/ 50 [micro]l) and overlaid with mineral oil and were then incubated in a humidified atmosphere of 5% C[O.sub.2] at 39 [degrees]C for 24 hr. Vitrification and warming

Vitrification was done based on Minimum Essential Volume (MEV) method using cryotop as cryodevice (16). Briefly, groups of five immature COCs were initially introduced into holding medium (HM) consisting of 20 mM HEPES-TCM supplemented with 20% (v/v) FBS for I min. The COCs were subsequently transferred into Vitrification Solution I (VS1) consisting of HM supplemented with 10% (v/v) Ethylene Glycol (EG) and 10% (v/v) dimethyl sulfoxide (DMSO) for 30 s and were then incubated in vitrification solution 2 (VS2) consisting of HM supplemented with 20% (v/v) EG, 20% (v/v) DMSO and 0.5 M sucrose for 20 s. The COCs were then loaded on cryotop (Kitazato Ltd., Tokyo, Japan) with the least medium (<0.1 [micro]l) and immediately plunged into liquid nitrogen. For warming, vitrified COCs were exposed to warming solution containing 1.25 M sucrose in HM for 1 min, followed by a second and third dilution in warming solutions containing 0.62 M and 0.31 M sucrose for 30 s of each.

In vitro fertilization

In vitro-matured COCs (n=1069) were fertilized with sheep sperm from a freezing batch of Shaal breed ram that had previously been successfully used in our laboratory. Semen was thawed at 36[degrees]C for 1 min, and was fractionated on discontinuous Percoll (Amersham Biosciences AB, Uppsala, Sweden) gradients as previously described (6). Sperm then were washed in HSOF [4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)-synthetic oviductal fluid] by centrifugation at 750xg for 10 min at room temperature and were diluted in IVF medium with final concentration of 1.0 x [10.sup.6] sperm/ml. Fertilization medium was Synthetic Oviductal Fluid (SOF), as previously indicated by Shirazi et al (18), supplemented with 20% (v/v) heat inactivated estrous sheep serum and 1% (w/v) heparin. Sperm suspension was added into the fertilization droplets containing 10 oocytes. Fertilization was done by coincubation of sperm and oocytes in an atmosphere of 5% C[O.sub.2] in humidified air at 39[degrees]C for 18 hr.

======= In vitro culture

After IVF, cumulus cells were removed by pipetting and the presumed denuded zygotes were placed in 20 pi culture drops (4-5 embryos/20 [micro]l IVC medium) containing SOF supplemented with 1% (v/v) MEM-non essential amino acids, 2% (v/v) BME- essential amino acids, 8 mg/ml fatty acid free Bovine Serum Albumin (BSA) and 1 mM glutamine and [10.sup.10] M Ang II on day 4 of IVC in Vit-D4 and D4 groups. Charcoal stripped FBS 10% (v/v) was added to the medium on the third and fifth day of culture. The osmolarity was maintained at 270 to 285 mOsmol. They were then cultured at 39[degrees]C under conditions of 7% [O.sub.2], 5% C[O.sub.2] and 88% [N.sub.2] in humidified air. The percentage of cleaved embryos on day 3 and the percentage of blastocysts on days 6 to 8 were calculated on the basis of the number of oocytes at the onset of culture, and the percentage of hatched blastocysts on days 7 and 8 was expressed based on the number of blastocysts at the same day.

Immunostaining and quantification of fluorescence intensity

The primary antibodies against [Na.sup.+]/[K.sup.+]/ATPase subunits ([Na.sup.+]/[K.sup.+]/ATPase anti-ai Monoclonal Antibody, Thermo scientific, Rockford, USA and [Na.sup.+]/[K.sup.+]/ATPase anti-[[beta].sub.1] Monoclonal Antibody, Abeam, Cambridge) were diluted at 1:50 (v/v) and 1:100 (v/v), respectively. The secondary antibody (sheep anti-mouse antibody conjugated with fluorescin isothiocyanate; Avicenna Research Institute, Tehran, Iran) was diluted at 1:50 (v/v) with antibody diluents. For immunostaining, first the embryos at morula and blastocyst stages were fixed and prepared as previously described (19) and then exposed to primary antibody solution at 37[degrees]C for 4 hr followed by transfer to the secondary antibody solution at 37 f for further 4 hr. In negative controls, the primary antibodies were omitted. After immunostaining, the embryos were directly mounted on a glass slide and examined under a Nikon TE 300 (Nikon Corporation, Melville, USA) epifluorescence microscope with excitation wavelengths of 488 run (for FITC). All images were prepared with a high-resolution Charge-Coupled Device (CCD) camera (Nikon Corporation) and duration of exposure for acquiring each type of fluorescence was kept constant. After subtracting the background, mean fluorescence intensity was measured by manually outlining all embryos with ImageJ 1.37v software (National Institutes of Health, Bethesda, MD, USA).

Statistical analysis

The differences among groups were analyzed by one-way ANOVA followed by post hoc Fisher LSD test using SigmaPlot (version 11.0). When equal variance test was failed, the treatments were compared by Student-Newman-Keuls method. When normality test was failed, the Kruskal-Wallis on ANOVA ranks was applied. Differences were considered significant when p<0.05. Data were expressed as mean[+ or -]SEM. Data were collected over at least four replicates.

Results

Effect of Ang II supplementation on embryo development

Addition of [10.sup.-10] M Ang II to IVM or IVC media in vitrified oocytes (IVM and D4 groups) significantly increased the rates of expanded and total blastocyst on day 7 (p=0.001 and p=0.02, respectively) as well as the greater proportion of total blastocyst on day 8 of culture (p<0.001) compared with control (Control-Vit group; Table 1). There was no significant difference in cleavage and expanded blastocyst rates on day 6 and hatched blastocyst rate on day 8 in vitrified groups with or without Ang II (Table 1).

Effect of Ang II supplementation on [Na.sup.+]/[K.sup.+]/ATPase subunits expression in embryos

There was a significant difference in [Na.sup.+]/[K.sup.+]/ATP ase subunit expression among treatment groups (Figure 1). The expression of [Na.sup.+]/[K.sup.+]/ATPase ct] and [[beta].sub.1] subunits when IVC medium was supplemented with Ang II (Figure 2; p=0.003 and p<0.001, respectively) significantly increased compared to the control. Media supplementation with Ang II during IVM, however, had no influence on expression of [Na.sup.+]/[K.sup.+]/ATPase [[alpha].sub.1] and [[beta].sub.1] subunits.

[FIGURE 1 OMITTED]

Discussion

According to the increased concentration of Ang II at the time of ovulation in follicular fluid (6), and considering the up regulation of [Na.sup.+/[K.sup.+]/ATPase at the time of embryonic genome activation, 8 to 16-cell stage (20,21), it was hypothesized that the addition of Ang II to the IVM and IVC media may play a significant role in sheep embryo development.

It has also been demonstrated that [Na.sup.+]/[K.sup.+]/ATPase expression is increased during morula to blastocyst transition (17,22,23). In our experimental condition, despite the general knowledge indicating the reductive role of cryopreservation on mRNA abundance, the expression of [Na.sup.+]/[K.sup.+]/ATPase in embryos derived from vitrified oocytes (Control-Vit group) was comparable to the embryos derived from fresh oocytes (Control-Fresh group). Nonetheless, the addition of Ang II to the IVC medium could increase [Na.sup.+]/[K.sup.+]/ATPase expression compared to other groups (Figure 1).

[FIGURE 2 OMITTED]

There are some evidences indicating the persuasive effect of Ang II on expression of [Na.sup.+]/[K.sup.+]/ATPase [[alpha].sub.1] and [[beta].sub.1], subunits in various cell types (14,24-26). it has also been shown that [Na.sup.+]/[K.sup.+]/ATPase has a fundamental role in regulating mouse trophectoderm tight junction formation and function (22). Inhibition of[Na.sup.+]/[K.sup.+]/ATPase by ouabain was associated with failure of constitution of an efficient trophectoderm tight junctional seal that is required for expansion of the blastocyst cavity and hatching (17). On the other hand, blastocyst expansion only occurs when the tight junction permeability seal fully forms, to restrict the leakage of fluid via paracellular routes, ensuring the expansion of the cavity as fluid accumulates (20).

As shown (Table 1), among vitrified oocytes, the proportions of blastocysts on days 6 to 8 as well as the proportion of expanded blastocysts on day 7 of IVC in both Vit-IVM and Vit-D4 groups were higher than the corresponding value in Control-Vit (Table 1).

Therefore, it could be hypothesized that in vitrified groups, the increased proportions of expanded and total blastocysts might be related to the inductive role of Ang II in [Na.sup.+]/[K.sup.+]/ATPase expression which in turn could regulate the function of trophectoderm tight junction. Furthermore, the presence of Ang II in human follicular fluid and localization of its receptors on COCs (12), once more may suggest its positive role in oocyte competence which in our study was reflected in terms of greater development of subsequent embryo in treatment groups compared to the control.

In our experimental condition, the positive effect of AngII on expression of [Na.sup.+]/[K.sup.+]/ATPase [[beta].sub.1] and [[beta].sub.1] subunits in vitrified oocytes was only evident when Ang II was added during IVC (Figure 2). One possibility for the lack of positive effect of Ang II supplementation during IVM on [Na.sup.+]/[K.sup.+]/ATPase subunits expression might be related to the time interval between Ang II supplementation (during IVM) and assessment of [Na.sup.+/[K.sup.+]/ ATPase [[alpha].sub.1] and [[beta].sub.1], expression (blastocyst stage on day 8). An increase in [Na.sup.+]/[K.sup.+]/ATPase genes expression during morula to blastocyst transition 22 may bring up the point that in our study condition the addition of Ang II on day 4 of IVC has a greater chance to affect [Na.sup.+]/[K.sup.+]/ATPase subunits expression in resulting morula and blastocysts compared to earlier stage supplementation (during IVM; Figure 2).

As demonstrated, [Na.sup.+]/[K.sup.+]/ATPase Pi subunit protein is required for blastocyst formation (17,21). In our study, the overall expression of [Na.sup.+]/[K.sup.+]/ATPase ][[beta].sub.1] subunit protein was greater than [[alpha].sub.1] subunit (Figure 2). Based on the documents, it seems [Na.sup.+]/[K.sup.+]/ATPase p, subunit oversees the proper localization of [Na.sup.+]/[K.sup.+]/ATPase [[alpha].sub.1] subunit to the cortical membrane regions of each blastomere and also induces the proper distribution and assembly of tight junction-associated polypeptides (ZO-1 and occludin) to the apical membrane regions between differentiating trophectoderm cells. In addition, it has been indicated that the [Na.sup.+]/[K.sup.+]/ATPase [[beta].sub.1] subunit is required to support early development to the morula (16-32 cells) stage of mouse embryos 17.

Other studies have demonstrated that [Na.sup.+]/[K.sup.+]/ ATPase [[beta].sub.1] subunit gene products display a dramatic up-regulation just before blastocyst formation suggesting up-regulation of this gene is required for cavitation and hatching process to occur. Based on what stated, it could be inferred that the up-regulation of [Na.sup.+]/[K.sup.+]/ ATPase [[beta].sub.1] subunit should have a greater positive impact on blastocyst and hatched blastocyst formation in Ang II treated groups compared to a, subunit (Table 1).

Concerning the [Na.sup.+]/[K.sup.+]/ATPase [[alpha].sub.1], subunit, as documented, its mRNAs are present throughout preimplantation development and display a much more gradual increase as the embryo progresses to the blastocyst stage (17,21). In our study, despite the lower expression of [[alpha].sub.1] compared to [[beta].sub.1] subunit, it seems it may have a role on blastocyst formation in embryos exposed to the Ang II during IVC.

Now the question arises that if the higher developmental competence of vitrified oocytes is related to the higher expression of[Na.sup.+]/[K.sup.+]/ATPase [[alpha].sub.1] and [[beta].sub.1] subunits, what the reason for the higher blastocyst rate is in Vit-IVM compared to Control-Vit group. Therefore, apart from the positive effect of Ang II on[Na.sup.+]/[K.sup.+]/ ATPase [[alpha].sub.1][[beta].sub.1] [[alpha].sub.1]q and [[beta].sub.1] expression, there must be another reason for the positive effect of Angll on blastocyst rate in Vit-IVM group which needs to be further investigated.

Conclusion

The addition of Ang II to the IVM and/or day 4 of IVC media significantly increased the rate of blastocyst in vitrified oocytes. The higher expression of[Na.sup.+]/[K.sup.+]/ ATPase [[alpha].sub.1] and [[beta].sub.1] subunits in embryos derived from vitrified oocytes might be the reason for the higher blastocyts rate in vitrified oocytes subjected to Angll during D4 of IVC.

Acknowledgement

The authors would like to thank Avicenna Research Institute (grant no. 90-32) for financial support and providing the opportunity to conduct the study.

References

(1.) Luciano AM, Chigioni S, Lodde V, Franciosi F, Luvoni GC, Modina SC. Effect of different cryopreservation protocols on cytoskeleton and gap junction mediated communication integrity in feline germinal vesicle stage oocytes. Cryobiology 2009;59(l):90-95.

(2.) Mullen SF, Fahy GM. A chronologic review of mature oocyte vitrification research in cattle, pigs, and sheep. Theriogenology 2012;78(8): 1709-1719.

(3.) Naderi MM, Borjian Boroujeni S, Sarvari A, Fleidari B, Akhondi MM, Zarnani AH, et al. The effect of angiotensin on the quality of in vitro produced (IVP) sheep embryos and expression of Na(+)/K(+)/ATPase. Avicenna J Med Biotechnol 2016;8(1):9-15.

(4.) Kojouri GA, Shirazi A. Serum concentrations of Cu, Zn, Fe, Mo and Co in newborn lambs following systemic administration of Vitamin E and selenium to the pregnant ewes. Small Rumin Res 2007;70(2-3): 136-139.

(5.) Shirazi A, Sadeghi N. The effect of ovine oocyte diameter on nuclear maturation. Small Rumin Res 2007;69(13): 103-107.

(6.) Stefanello JR, Barreta MH, Porciuncula PM, Arruda JN, Oliveira JF, Oliveira MA, et al. Effect of angiotensin II with follicle cells and insulin-like growth factor-I or insulin on bovine oocyte maturation and embryo development. Theriogenology 2006;66(9):2068-2076.

(7.) Sirard MA, Lambert RD. Birth of calves after in vitro fertilisation using laparoscopy and rabbit oviduct incubation of zygotes. Vet Rec 1986; 119(8): 167-169.

(8.) Sarvari A, Naderi MM, Sadeghi MR, Akhondi MM. A technique for facile and precise transfer of mouse embryos. Avicenna J Med Biotechnol 2013;5(l):62-65.

(9.) Schauser KH, Nielsen AH, Winther H, Dantzer V, Poulsen K. Dominance of type 1 angiotensin II receptor in the nonpregnant and pregnant bovine uterus. J Reprod Fertil 1999; 116(2):403-413.

(10.) Wijayagunawardane MP, Kodithuwakku SP, DE Silva NT, Miyamoto A. Angiotensin II secretion by the bovine oviduct is stimulated by luteinizing hormone and ovarian steroids. J Reprod Dev 2009;55(5):570-575.

(11.) Pijacka W, Hunter MG, Broughton Pipkin F. Luck MR. Expression of renin-angiotensin system components in the early bovine embryo. Endocr Connect 2012; 1 (1):22-30.

(12.) Honorato-Sampaio K, Pereira VM, Santos RA, Reis AM. Evidence that angiotensin-(l-7) is an intermediate of gonadotrophin-induced oocyte maturation in the rat preovulatory follicle. Exp Physiol 2012;97(5):642-650.

(13.) Giometti IC, Bertagnolli AC, Ornes RC, da Costa LF, Carambula SF, Reis AM, et al. Angiotensin II reverses the inhibitory action produced by theca cells on bovine oocyte nuclear maturation. Theriogenology 2005:63(4): 1014-1025.

(14.) Muscella A, Aloisi F, Marsigliante S, Levi G. Angiotensin II modulates the activity of Na+,K+-ATPase in cultured rat astrocytes via the ATI receptor and protein kinase C-delta activation..1 Neurochem 2000;74(3): 1325-1331.

(15.) Min LJ, Mogi M, Iwai M, Horiuchi M. Signaling mechanisms of angiotensin II in regulating vascular senescence. Ageing Res Rev 2009:8(2): 113-121.

(16.) Succu S, Bebbere D, Bogliolo L, Ariu F, Fois S, Leoni GG, et al. Vitrification of in vitro matured ovine oocytes affects in vitro pre-implantation development and mRNA abundance. Mol Reprod Dev 2008;75(3):538-546.

(17.) Madan P, Rose K, Watson AJ. Na/K-ATPase betal subunit expression is required for blastocyst formation and normal assembly of trophectoderm tight junction-associated proteins. J Biol Chem 2007;282(16):12127-12134.

(18.) Shirazi A, Ardali MA, Ahmadi E, Nazari H, Mamuee M, Heidari B. The effect of macromolecule source and type of media during in vitro maturation of sheep oocytes on subsequent embryo development. J Reprod Infertil 2012;13(1): 13-19.

(19.) Naderi MM, Sarvari A, Saviz A, Naji T, Borjian Borou jeni S, Heidari B, et al. The effect of aldosterone on Na+/ K+/ATPase expression and development of embryos derived from vitrified-warmed sheep oocytes. Small Rumin Res 2015;126:44-51.

(20.) Lim JM, Hansel W. Exogeneous substances affecting development of in vitro-derived bovine embryos before and after embryonic genome activation. Theriogenology 2000:53(5): 108*1-109 L

(21.) Houghton FD. Humpherson PG, Hawkhead JA, Hall CJ. Leese HI. Na+, K+, ATPase activity in the human and bovine preimplantation embryo. Dev Biol 2003:263(2): 360-366.

(22.) Gomez E, Caamano JN, Bermejo-Alvarez P, Diez C, Munoz M, Martin D, et al. Gene expression in early expanded parthenogenetic and in vitro fertilized bovine blastocysts. J Reprod Dev 2009;55(6):607-614.

(23.) Violette MI, Madan P, Watson AJ. [Na.sup.+]/[K.sup.+]-ATPase regulates tight junction formation and function during mouse preimplantation development. Dev Biol 2006:289 (2):406-419.

(24.) Gomes CP, Leao-Ferreira LR, Caruso-Neves C, Lopes AG. Adenosine reverses the stimulatory effect of angiotensin II on the renal Na+-ATPase activity through the A2 receptor. Regul Pept 2005; 129(1-3):9-15.

(25.) Lara LS, De Carvalho T, Leao-Ferreira LR, Lopes AG, Caruso-Neves C. Modulation of the (Na(+)+K+)ATPase activity by Angiotensin-(l-7) in MDCK cells. Regul Pept 2005; 129(1-3):221 -226.

(26.) Isenovic ER, Jacobs DB. Kedees MH, Sha Q, Milivojevic N, Kawakami K, et al. Angiotensin II regulation of the Na+ pump involves the phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways in vascular smooth muscle cells. Endocrinology 2004;145(3): 1151-1160.

Mohammad Mehdi Naderi [1]([dagger]), Sara Borjian Boroujeni [1]([dagger]), Ali Satvari [1], Banafsheh Heidari Mohammad Mehdi Ahhondi [1], Amir-Hassan Zarnani [2], and Abolfazl Shirazi [1,3] *

[1.] Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran

[2.] Reproductive Immunology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran

[3.] Research Institute of Animal Embryo Technology, Shahrekord University, Shahrekord, Iran

([dagger]) These authors equally contributed to this work

* Corresponding author:

Abolfazi Shirazi, Ph.D., Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran

Tel: +98 9131821238

Fax: +98 21 22404145

E-mail: shiraziabbas@yahoo.com, a.shirazi@avicenna.ac.ir.

Received: 23 Nov 2015

Accepted: 27 Jan 2016
Table 1. The presence of angiotensin in culture media during
IVM or Day 4 of IVC on embryo development

                 Oocyte            Cleavage
Group              N                 N (%)

Control-Fresh     152      130(85.2 [+ or -] 7) (a)
Control-Vit       240      112(46 [+ or -] 2.2) (b)
Vit-IVM           322     158(48.5 [+ or -] 2.3) (b)
Vit-D4            355     191(52.3  [+ or -] 2.1) (b)
p-value            --               p<.001

                     Blastocyst % (mean [+ or -] SEM)

                                   Day 6

Group                 Expanded               Total

Control-Fresh    38.9 [+ or -] 14.2    9.9 [+ or -] 1 (a)
Control-Vit       50 [+ or -] 20.4    3.2 [+ or -] 1.2 (b)
Vit-IVM          48.7 [+ or -] 0.7    5.7 [+ or -] 1.1 (c)
Vit-D4            67 [+ or -] 5.2     7.7 [+ or -] 1.1 (c)
p-value           p [greater than            p=0.07
                 or equal to] 0.05

                        Blastocyst % (mean [+ or -] SEM)

                                        Day 7

Group                   Expanded                Hatched

Control-Fresh     57.3 [+ or -] 6.6 (a)    21.6 [+ or -] 5.8
Control-Vit      16.6 [+ or -] 11.8 (b)    18.5 [+ or -] 11.3
Vit-IVM           61.5 [+ or -] 2.1 (a)     14.6 [+ or -] 1
Vit-D4             66 [+ or -] 3.5 (a)     13.4 [+ or -] 1.4
p-value                  p=0.001            p [greater than
                                           or equal to] 0.05

                 Blastocyst % (mean [+ or -] SEM)

                               Day 7

Group                          Total

Control-Fresh            23 [+ or -] 5 (a)
Control-Vit            5.6 [+ or -] 1.9 (b)
Vit-IVM                12.9 [+ or -] 1.6 (c)
Vit-D4                 16.5 [+ or -] 1.5 (c)
p-value                       p=0.02

                         Blastocyst % (mean4SEM)

                                  Day 8

Group                 Hatched                Total

Control-Fresh    36.2 [+ or -] 2.3   35.4 [+ or -] 4.3 (a)
Control-Vit        25 [+ or -] 9     7.1 [+ or -] 1.4 (b)
Vit-IVM          21.5 [+ or -] 1.2    14.7 [+ or -] 1 (c)
Vit-D4           22.6 [+ or -] 0.9   17.7 [+ or -] 1.4 (c)
p-value           p [greater than           p<0.001
                 or equal to] 0.05

(a, b) Numbers with different lowercase superscript letters
in the same column differ significantly.

The percentage of blastocysts at days 6 to 8 were expressed
based on oocytes number at the onset of culture, and the
percentages of expanded and hatched blastocysts at days 7
and 8 were expressed based on the total number of
blastocysts at the same day.
COPYRIGHT 2016 Avicenna Research Institute
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Original Article
Author:Naderi, Mohammad Mehdi; Boroujeni, Sara Borjian; Sarvari, Ali; Heidari, Banafsheh; Akhondi, Mohammad
Publication:Avicenna Journal of Medical Biotechnology (AJMB)
Article Type:Report
Date:Jul 1, 2016
Words:4538
Previous Article:Effect of removal of Spermatogonial Stem Cells (SSCs) from in vitro culture on gene expression of niche factors in bovine.
Next Article:Leptin receptor gene polymorphism may affect subclinical atherosclerosis in patients with acromegaly.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |